Literature DB >> 16831139

Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice.

John L Phillips1, Ingrid C Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16831139     DOI： 10.1111/j.1464-410X.2006.06189.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

1.  Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.

Authors:  Shizhen Zhang; Yan Wang; Jolanta Bondaruk; Tadeusz Majewski; Hui Yao; Sangkyou Lee; June Goo Lee; David Cogdell; Yair Lotan; Colin Dinney; Peng Wei; Keith Baggerly; Bogdan Czerniak
Journal:  Eur Urol Focus       Date:  2018-02-07

2.  The frequencies of micronuclei, nucleoplasmic bridges and nuclear buds as biomarkers of genomic instability in patients with urothelial cell carcinoma.

Authors:  Arjeta Podrimaj-Bytyqi; Ana Borovečki; Qerim Selimi; Suzana Manxhuka-Kerliu; Goneta Gashi; Isa R Elezaj
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

3.  Diagnostic Value Comparison of Urothelium Carcinoma Among Urine Exfoliated Cells Fluorescent In Situ Hybridization (FISH) Examination, Computerized Tomography (CT) Scan, and Urine Cytologic Examination.

Authors:  Tao Yang; Yan Li; Jing Li; Junjiang Liu; Xinna Deng; Gang Wang
Journal:  Med Sci Monit       Date:  2018-08-19

Review 4.  Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer.

Authors:  Uttam Satyal; Abhishek Srivastava; Philip H Abbosh
Journal:  Front Oncol       Date:  2019-11-19       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.